Column Group L P has bought stock on 39 days since Sep 2016
Director and 10% owner at Ngm Biopharmaceuticals Inc, and 2 other companies
SEC CIK 0001347769 · Filings on SEC.gov ↗
Column Group L P's record
3 months after each buy, from the first price a copier could get.
5 buys since 2016 with 3 months of prices.
Companies
Every filing
41 filings since Sep 2016, newest first
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Constellation Pharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
Director and 10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Constellation Pharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Constellation Pharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Ngm Biopharmaceuticals Inc
10% owner
Immune Design Corp.
10% owner
Immune Design Corp.
10% owner
Filings come from SEC EDGAR. Not investment advice.